Bioequivalence Study of Empagliflozin
01-EMP-BIO-25
Phase 1 other active
Quick answer
Bioequivalence Study of Empagliflozin for Not applicable (submitted trial is a BE study in healthy participants) is a Phase 1 program (other) at Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
- Indication
- Not applicable (submitted trial is a BE study in healthy participants)
- Phase
- Phase 1
- Modality
- other
- Status
- active